Actively Recruiting
Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe
Led by Jianhui Tian · Updated on 2024-05-03
356
Participants Needed
5
Research Sites
148 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To address the clinical challenge of postoperative metastasis in stage IIA-IIIA non-small cell lung cancer with negative driver gene expression, there is a lack of effective diagnostic and therapeutic measures. Based on this, investigators propose to carry out a clinical study on the prevention and treatment of postoperative metastasis of IIA-IIIA stage lung cancer with negative driver gene expression with the formula of supporting the positive and dispelling the evil.
CONDITIONS
Official Title
Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with clinical stage IIA-IIIA lung adenocarcinoma who have undergone radical surgery within the last 6 weeks
- Negative driver gene expression (no EGFR, ALK, ROS1 mutations) and PD-1/L1 expression <1%
- Diagnosis of Qi-Yin Deficiency Syndrome with at least two primary symptoms and one secondary symptom
- Age between 18 and 75 years
- Normal blood and biochemical tests without serious infections or organ failure
- Tumor PS score ≤2 and no serious comorbidities
- Informed consent signed with good compliance
- Non-pregnant and not lactating
- Passing chemotherapy-related tests
- No allergy to the formula ingredients
You will not qualify if you...
- Incomplete tumor resection or presence of recurrence or metastasis
- Receiving other drugs or therapies such as Chinese herbal medicines, immunological drugs, or radiotherapy
- Mental illness or lack of autonomous behavior
- Pregnant, planning pregnancy, or breastfeeding women
- Serious diseases affecting heart, lung, brain, liver, kidney, or hematopoietic system
- Allergy or hypersensitivity to the drug components
- Participation in other clinical trials within the last 3 months
- Abuse of alcohol, psychoactive substances, or drugs
- Other conditions judged by investigators to complicate enrollment or follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Shanghai Chest Hospital
Changning, Shanghai Municipality, China
Actively Recruiting
2
Shanghai General Hospital
Hongkou, Shanghai Municipality, China
Actively Recruiting
3
Shanghai Traditional Chinese Medicine-Integrated Hospital
Hongkou, Shanghai Municipality, China
Actively Recruiting
4
Shanghai Municipal Hospital of Traditional Chinese Medicine
Jing’an, Shanghai Municipality, China, 200071
Actively Recruiting
5
Shanghai Pulmonary Hospital
Yangpu, Shanghai Municipality, China
Actively Recruiting
Research Team
J
Jianhui Tian, professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here